|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current assets | |||||||||||||
| Cash | |||||||||||||
| Prepaid expenses | |||||||||||||
| Due from related party | |||||||||||||
| Total current assets | |||||||||||||
| Cash held in Trust Account | |||||||||||||
| Total Assets | |||||||||||||
| Current liabilities | |||||||||||||
| Accounts payable and accrued expenses | |||||||||||||
| Convertible senior secured promissory note | |||||||||||||
| Derivative liability | |||||||||||||
| Sponsor convertible notes | |||||||||||||
| Related Party | |||||||||||||
| Total sponsor convertible notes | |||||||||||||
| Total current liabilities | |||||||||||||
| Non-current liabilities | |||||||||||||
| Warrant liability | |||||||||||||
| Deferred underwriting commissions | |||||||||||||
| Warrant liabilities | |||||||||||||
| Total non-current liabilities | |||||||||||||
| Total Liabilities | |||||||||||||
| Redeemable Class A ordinary shares, $0.0001 par value; 200,000,000 shares authorized, 23,000,000 shares issued and outstanding subject to possible redemption, at redemption value at March 31, 2022 and December 31, 2021 | |||||||||||||
| Redeemable Class A ordinary shares, $0.0001 par value; 200,000,000 shares authorized, 23,000,000 shares issued and outstanding subject to possible redemption, at redemption value | |||||||||||||
| CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION | |||||||||||||
| Class A ordinary shares subject to possible redemption, $0.0001 par value; 332,928 and 4,777,672 shares issued and outstanding subject to possible redemption, at approximately $11.58 and $11.07 redemption value at December 31, 2024 and 2023, respectively | |||||||||||||
| SHAREHOLDERS’ DEFICIT | |||||||||||||
| Preference shares, $0.0001 par value; 1,000,000 shares authorized; 609,250 issued and outstanding and none issued or outstanding at December 31, 2024 and 2023, respectively | |||||||||||||
| Ordinary shares value | |||||||||||||
| Class A Ordinary Shares | |||||||||||||
| Class B Ordinary Shares | |||||||||||||
| Total ordinary shares value | |||||||||||||
| Class B ordinary shares; $0.0001 par value; 20,000,000 shares authorized; one and 5,750,000 shares issued and outstanding, respectively, at September 30, 2023 and December 31, 2022 | |||||||||||||
| Additional paid-in capital | |||||||||||||
| Accumulated deficit | |||||||||||||
| Total Shareholders’ Deficit | |||||||||||||
| Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit |
Loading...
